BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3912921)

  • 1. Cyclophosphamide derivatives for in vitro cleansing of leukemic bone marrow.
    Douay L
    Rev Fr Transfus Immunohematol; 1985 Nov; 28(5):427-36. PubMed ID: 3912921
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological purging of bone marrow with drugs other than cyclophosphamide derivatives.
    Gorin NC
    Rev Fr Transfus Immunohematol; 1985 Nov; 28(5):437-46. PubMed ID: 2419956
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological purging of bone marrow with reference to autografting.
    Santos GW; Colvin OM
    Clin Haematol; 1986 Feb; 15(1):67-83. PubMed ID: 2421955
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxicity of ASTA Z 7557 (INN mafosfamide) to normal- and leukemic stem cells: implications for autologous bone marrow transplantation.
    Hagenbeek A; Martens AC
    Invest New Drugs; 1984; 2(2):237-43. PubMed ID: 6381383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma interacts with mafosfamide toxicity to normal haematopoietic progenitor cells: impact on in vitro marrow purging.
    Giarratana MC; Gorin NC; Douay L
    Nouv Rev Fr Hematol (1978); 1995; 37(2):125-30. PubMed ID: 7644349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous marrow transplantation and the extracorporeal separability of normal and leukemic cells.
    Wheldon TE
    Int J Radiat Oncol Biol Phys; 1978; 4(7-8):753-4. PubMed ID: 361659
    [No Abstract]   [Full Text] [Related]  

  • 7. Competitive repopulation in leukemic and normal bone marrow.
    Brecher G; Pallavicini MG; Cronkite EP
    Blood Cells; 1993; 19(3):691-7; discussion 698-707. PubMed ID: 8018950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purging by dye-mediated photosensitization.
    Porcellini A; Manna M; Marchetti-Rossi MT; Sparaventi G
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():188-9. PubMed ID: 2653501
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of cyclophosphamide on mouse bone marrow and leukemic stem cells.
    Paprocka M; Budzyński W; Kuśnierczyk H; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1980; 28(3):447-51. PubMed ID: 7447649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide/X-ray: combined mode preparation for transplantation therapy.
    Meredith R; OKunewick J; Shadduck R; Raikow R; Brozovich B; Seeman P
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1467-70. PubMed ID: 395138
    [No Abstract]   [Full Text] [Related]  

  • 11. Autologous bone marrow transplantation (A.B.M.T.) in children with acute lymphoblastic leukemia (A.L.L.).
    Plouvier E; Noir A; Hervé P
    Rev Fr Transfus Immunohematol; 1985 Nov; 28(5):503-8. PubMed ID: 3912927
    [No Abstract]   [Full Text] [Related]  

  • 12. Separation of normal hemopoietic stem cells from clonogenic leukemic cells in a rat model for human acute myelocytic leukemia.-I. Velocity sedimentation.
    Hagenbeek A; Martens AC; van Bekkum DW
    Leuk Res; 1981; 5(4-5):421-8. PubMed ID: 7026905
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of 4-hydroperoxycyclophosphamide on leukemic and normal human myeloid progenitor cells.
    Delforge A; Loos M; Stryckmans P; Socquet M; Debusscher L; Rongé-Collard E
    Leuk Res; 1985; 9(5):583-6. PubMed ID: 3859709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental bases of the in vitro treatment of leukemic bone marrow by a derivative of cyclophosphamide: ASTA Z 7557].
    Douay L; Gorin NC; Mary JY; Duhamel G
    C R Acad Sci III; 1985; 301(6):303-8. PubMed ID: 3928107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization and characterization of the procedure for in vitro treatment of human bone marrow with cyclophosphamide derivatives.
    Lopez M; Du Puymontbrun MC; Douay L; Laporte JP; Gorin NC
    Clin Lab Haematol; 1985; 7(4):327-34. PubMed ID: 3913559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined ex vivo treatment with immunotoxins and mafosfamid: a novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts.
    Uckun FM; Stong RC; Youle RJ; Vallera DA
    J Immunol; 1985 May; 134(5):3504-15. PubMed ID: 3884712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo elimination of lymphoblastic leukemia cells from human marrow by mafosfamid.
    Uckun FM; Ramakrishnan S; Haag D; Houston LL
    Leuk Res; 1985; 9(1):83-95. PubMed ID: 3887044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of in vitro treatment with 4-hydroperoxycyclophosphamide and hyperthermia on leukemic progenitor cells.
    Minegishi N; Minegishi M; Tsuchiya S; Konno T
    Tohoku J Exp Med; 1989 Oct; 159(2):101-11. PubMed ID: 2609329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone marrow transplantation in adult ALL. A French survey of 32 patients.
    Flesch M; Hervé P
    Rev Fr Transfus Immunohematol; 1985 Nov; 28(5):489-502. PubMed ID: 3912926
    [No Abstract]   [Full Text] [Related]  

  • 20. Autologous bone marrow transplantation in acute leukemia and non-Hodgkin's lymphoma: a phase I study of 4-hydroperoxycyclophosphamide (4HC) incubation of marrow prior to cryopreservation.
    Kaizer H; Tutschka P; Stuart R; Korbling M; Braine H; Saral R; Colvin M; Santos G
    Haematol Blood Transfus; 1983; 28():90-1. PubMed ID: 6345299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.